Frank S Cikach1, Adriano R Tonelli2, Jarrod Barnes1, Kelly Paschke1, Jennie Newman2, David Grove1, Luma Dababneh1, Sihe Wang3, Raed A Dweik4. 1. Pathobiology Department, Lerner Research Institute, Cleveland Clinic, Cleveland, OH. 2. Department of Pulmonary, Allergy and Critical Care Medicine, Respiratory Institute, Cleveland Clinic, Cleveland, OH. 3. Department of Clinical Pathology, Cleveland Clinic, Cleveland, OH. 4. Pathobiology Department, Lerner Research Institute, Cleveland Clinic, Cleveland, OH. Electronic address: dweikr@ccf.org.
Abstract
BACKGROUND: Pulmonary arterial hypertension (PAH) is a progressive and devastating condition characterized by vascular cell proliferation and is associated with several metabolic derangements. We hypothesized that metabolic derangements in PAH can be detected by measuring metabolic by-products in exhaled breath. METHODS: We collected breath and blood samples from patients with PAH at the time of right-sided heart catheterization (n=31) and from healthy control subjects (n=34). Breath was analyzed by selected ion flow tube-mass spectrometry in predetermined training and validation cohorts. RESULTS: Patients with PAH were 51.5±14 years old, and 27 were women (85%). Control subjects were 38±13 years old, and 22 were women (65%). Discriminant analysis in the training set identified three ion peaks (H3O+29+, NO+56+, and O2+98+) and the variable age that correctly classified 88.9% of the individuals. In an independent validation cohort, 82.8% of the individuals were classified correctly. The concentrations of the volatile organic compounds 2-propanol, acetaldehyde, ammonia, ethanol, pentane, 1-decene, 1-octene, and 2-nonene were different in patients with PAH compared with control subjects. Exhaled ammonia was higher in patients with PAH (median [interquartile range]: 94.7 parts per billion (ppb) [70-129 ppb] vs 60.9 ppb [46-77 ppb], P<.001) and was associated with right atrial pressure (ρ=0.57, P<.001), mean pulmonary artery pressure (ρ=0.43, P=.015), cardiac index by thermodilution (ρ=-0.39, P=.03), pulmonary vascular resistance (ρ=0.40, P=.04), mixed venous oxygen (ρ=-0.59, P<.001), and right ventricular dilation (ρ=0.42, P=.03). CONCLUSIONS: Breathprint is different between patients with PAH and healthy control subjects. Several specific compounds, including ammonia, were elevated in the breath of patients with PAH. Exhaled ammonia levels correlated with severity of disease.
BACKGROUND:Pulmonary arterial hypertension (PAH) is a progressive and devastating condition characterized by vascular cell proliferation and is associated with several metabolic derangements. We hypothesized that metabolic derangements in PAH can be detected by measuring metabolic by-products in exhaled breath. METHODS: We collected breath and blood samples from patients with PAH at the time of right-sided heart catheterization (n=31) and from healthy control subjects (n=34). Breath was analyzed by selected ion flow tube-mass spectrometry in predetermined training and validation cohorts. RESULTS:Patients with PAH were 51.5±14 years old, and 27 were women (85%). Control subjects were 38±13 years old, and 22 were women (65%). Discriminant analysis in the training set identified three ion peaks (H3O+29+, NO+56+, and O2+98+) and the variable age that correctly classified 88.9% of the individuals. In an independent validation cohort, 82.8% of the individuals were classified correctly. The concentrations of the volatile organic compounds 2-propanol, acetaldehyde, ammonia, ethanol, pentane, 1-decene, 1-octene, and 2-nonene were different in patients with PAH compared with control subjects. Exhaled ammonia was higher in patients with PAH (median [interquartile range]: 94.7 parts per billion (ppb) [70-129 ppb] vs 60.9 ppb [46-77 ppb], P<.001) and was associated with right atrial pressure (ρ=0.57, P<.001), mean pulmonary artery pressure (ρ=0.43, P=.015), cardiac index by thermodilution (ρ=-0.39, P=.03), pulmonary vascular resistance (ρ=0.40, P=.04), mixed venous oxygen (ρ=-0.59, P<.001), and right ventricular dilation (ρ=0.42, P=.03). CONCLUSIONS: Breathprint is different between patients with PAH and healthy control subjects. Several specific compounds, including ammonia, were elevated in the breath of patients with PAH. Exhaled ammonia levels correlated with severity of disease.
Authors: Peter J Barnes; Raed A Dweik; Arthur F Gelb; Peter G Gibson; Steven C George; Hartmut Grasemann; Ian D Pavord; Felix Ratjen; Philip E Silkoff; D Robin Taylor; Noe Zamel Journal: Chest Date: 2010-09 Impact factor: 9.410
Authors: Reda E Girgis; Hunter C Champion; Gregory B Diette; Roger A Johns; Solbert Permutt; J T Sylvester Journal: Am J Respir Crit Care Med Date: 2005-05-05 Impact factor: 21.405
Authors: W H Wilson Tang; Zeneng Wang; Bruce S Levison; Robert A Koeth; Earl B Britt; Xiaoming Fu; Yuping Wu; Stanley L Hazen Journal: N Engl J Med Date: 2013-04-25 Impact factor: 91.245
Authors: Michael A Samara; W H Wilson Tang; Frank Cikach; Zeynep Gul; Lily Tranchito; Kelly M Paschke; Jamie Viterna; Yuping Wu; Daniel Laskowski; Raed A Dweik Journal: J Am Coll Cardiol Date: 2013-04-02 Impact factor: 24.094
Authors: Abigail V Rutter; Thomas W E Chippendale; Ying Yang; Patrik Španěl; David Smith; Josep Sulé-Suso Journal: Analyst Date: 2012-11-07 Impact factor: 4.616
Authors: Jarrod W Barnes; Adriano R Tonelli; Gustavo A Heresi; Jennie E Newman; Noël E Mellor; David E Grove; Raed A Dweik Journal: Pulm Circ Date: 2016-12 Impact factor: 3.017
Authors: David Grove; Galen Miller-Atkins; Celia Melillo; Florian Rieder; Satya Kurada; Daniel M Rotroff; Adriano R Tonelli; Raed A Dweik Journal: J Breath Res Date: 2020-05-27 Impact factor: 3.262
Authors: Jacob T Mey; Mary C Rath; Kathleen McLaughlin; Marianne Galang; Kathryn Lynch; Jaime DiMattio; Hillary Nason; Shengping Yang; Celia A Melillo; David E Grove; Adriano R Tonelli; Gustavo A Heresi; John P Kirwan; Raed A Dweik Journal: JPEN J Parenter Enteral Nutr Date: 2021-11-12 Impact factor: 3.896
Authors: David J Beale; Oliver A H Jones; Avinash V Karpe; Saravanan Dayalan; Ding Yuan Oh; Konstantinos A Kouremenos; Warish Ahmed; Enzo A Palombo Journal: Int J Mol Sci Date: 2016-12-23 Impact factor: 5.923
Authors: Jarrod W Barnes; Liping Tian; Stefanie Krick; E Scott Helton; Rebecca S Denson; Suzy A A Comhair; Raed A Dweik Journal: Int J Mol Sci Date: 2019-12-13 Impact factor: 5.923
Authors: Kelley L Colvin; Melanie J Dufva; Ryan P Delaney; D Dunbar Ivy; Kurt R Stenmark; Michael E Yeager Journal: Front Pediatr Date: 2014-02-03 Impact factor: 3.418